Annual SG&A
$114.33M$74.03M-39.30%
Summary
- Current Value
- As of today, AMLX annual SG&A is $114.33M, down -39.30% on
- Historical Performance
- AMLX annual SG&A is up +193.66% over the past 3 years, and up +3610.84% over the past 5 years
- All-Time High Comparison
- AMLX annual SG&A is currently -39.30% below its historical high of $188.36M set on
- 3-Year Low Comparison
- AMLX annual SG&A is at its 3-year low
- Sector Comparison
- AMLX annual SG&A is higher than 84.22% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $114.33M | -39.3% | +193.7% | +3610.8% | +3610.8% | |
| Quarterly SG&A | $16.17M | -9.3% | -46.0% | +100.0% | +100.0% | |
| TTM SG&A | -$2.65B | -1874.0% | -2720.2% | -100.0% | -100.0% | |
| Price | $16.92 | +390.4% | -54.1% | – | – | |
| Annual Operating Expenses | $254.62M | -19.6% | +207.9% | +1778.5% | +1778.5% | |
| Annual Operating Profit | -$291.88M | -852.2% | -253.0% | -2053.5% | -2053.5% | |
| Annual D&A | $904.00K | -16.9% | +1638.5% | +100.0% | +100.0% | |
| Annual Revenue | $87.37M | -77.1% | +10000.0% | +6027.0% | +6027.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $188.36M | -39.3% | |
| 5Y | $188.36M | -39.3% | |
| All | $188.36M | -39.3% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $114.33M | at low | |
| 5Y | $15.06M | N/A | +659.1% |
| All | $3.08M | +3610.8% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $114.33M | -39.3% | |
| $188.36M | +48.2% | |
| $127.13M | +226.5% |
| Year | Value | Change |
|---|---|---|
| $38.93M | +158.5% | |
| $15.06M | +388.8% | |
| $3.08M | - |
FAQ
What is the current annual SG&A of AMLX?
As of today, AMLX annual SG&A is $114.33M
What is 1-year change in AMLX annual SG&A?
AMLX annual SG&A is down -39.30% year-over-year
What is 3-year change in AMLX annual SG&A?
AMLX annual SG&A is up +193.66% over the past 3 years
How far is AMLX annual SG&A from its all-time high?
AMLX annual SG&A is currently -39.30% below its historical high of $188.36M set on December 31, 2023
How does AMLX annual SG&A rank versus sector peers?
AMLX annual SG&A is higher than 84.22% of companies in Healthcare sector
When is AMLX next annual earnings release?
The next annual earnings release for AMLX is on
Quarterly SG&A
$16.17M$532.00K+3.40%
Summary
- Current Value
- As of today, AMLX quarterly SG&A is $16.17M, up +3.40% on
- Historical Performance
- AMLX quarterly SG&A is down -9.29% year-over-year, and down -45.99% over the past 3 years
- All-Time High Comparison
- AMLX quarterly SG&A is currently -72.00% below its historical high of $57.76M set on
- 3-Year Low Comparison
- AMLX quarterly SG&A is +3.40% above its 3-year low of $15.64M reached on
- Sector Comparison
- AMLX quarterly SG&A is higher than 77.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $16.17M | +3.4% | -9.3% | -46.0% | +100.0% | |
| Annual SG&A | $114.33M | – | -39.3% | +193.7% | +3610.8% | |
| TTM SG&A | -$2.65B | -4102.7% | -1874.0% | -2720.2% | -100.0% | |
| Price | $16.92 | +10.7% | +390.4% | -54.1% | – | |
| Quarterly Operating Expenses | $35.91M | -15.9% | -7.6% | -34.3% | – | |
| Quarterly Operating Profit | -$36.03M | +15.9% | +8.7% | +34.1% | – | |
| Quarterly D&A | $120.00K | -14.9% | -45.7% | -27.3% | – | |
| Quarterly Revenue | $0.00 | 0.0% | -100.0% | -100.0% | 0.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.10M | N/A | -5.4% |
| 3Y | $57.76M | -72.0% | |
| 5Y | $57.76M | -72.0% | |
| All | $57.76M | -72.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $15.64M | +3.4% | |
| 3Y | $15.64M | +3.4% | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of AMLX?
As of today, AMLX quarterly SG&A is $16.17M
What is AMLX quarterly SG&A most recent change?
AMLX quarterly SG&A was up +3.40% on September 30, 2025
What is 1-year change in AMLX quarterly SG&A?
AMLX quarterly SG&A is down -9.29% year-over-year
How far is AMLX quarterly SG&A from its all-time high?
AMLX quarterly SG&A is currently -72.00% below its historical high of $57.76M set on March 31, 2024
How does AMLX quarterly SG&A rank versus sector peers?
AMLX quarterly SG&A is higher than 77.37% of companies in Healthcare sector
When is AMLX next earnings release?
The next earnings release for AMLX is on
TTM SG&A
-$2.65B$149.28M-5.97%
Summary
- Current Value
- As of today, AMLX TTM SG&A is -$2.65B, down -5.97% on
- Historical Performance
- AMLX TTM SG&A is down -1874.05% year-over-year, and down -2720.19% over the past 3 years
- All-Time High Comparison
- AMLX TTM SG&A vs all-time high is unknown
- 3-Year Low Comparison
- AMLX TTM SG&A is at its 3-year low
- Sector Comparison
- AMLX TTM SG&A is higher than 19.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$2.65B | -4102.7% | -1874.0% | -2720.2% | -100.0% | |
| Annual SG&A | $114.33M | – | -39.3% | +193.7% | +3610.8% | |
| Quarterly SG&A | $16.17M | +3.4% | -9.3% | -46.0% | +100.0% | |
| Price | $16.92 | +10.7% | +390.4% | -54.1% | – | |
| TTM Operating Profit | -$157.34M | +2.1% | +26.2% | +15.0% | – | |
| TTM D&A | $577.00K | -14.9% | -44.8% | +76.5% | – | |
| TTM Revenue | -$665.00K | -167.1% | -100.3% | -292.8% | -100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.10B | N/A | -26.5% |
| 3Y | -$1.13B | N/A | -135.3% |
| 5Y | -$67.91M | N/A | -3804.6% |
| All | $0.00 | N/A |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.65B | N/A | at low |
| 3Y | -$2.65B | N/A | at low |
| 5Y | -$2.65B | N/A | at low |
| All | -$2.65B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of AMLX?
As of today, AMLX TTM SG&A is -$2.65B
What is AMLX TTM SG&A most recent change?
AMLX TTM SG&A was down -5.97% on September 30, 2025
What is 1-year change in AMLX TTM SG&A?
AMLX TTM SG&A is down -1874.05% year-over-year
How far is AMLX TTM SG&A from its all-time high?
AMLX TTM SG&A vs all-time high is unknown
How does AMLX TTM SG&A rank versus sector peers?
AMLX TTM SG&A is higher than 19.98% of companies in Healthcare sector
When is AMLX next earnings release?
The next earnings release for AMLX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- AMLX Official Website amylyx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1658551/000119312525268059/0001193125-25-268059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000095017025031309/0000950170-25-031309-index.htm
- AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
- AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx